These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 31085793)

  • 1. Trends of Extemporaneous Drug Prescription in Latvia in 2017.
    Kiselova O; Maurina B; Sidlovska V; Rogovska I
    Int J Pharm Compd; 2019; 23(3):245-249. PubMed ID: 31085793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of Extemporaneously Compounded Nasal Preparations Prescribed by Latvian Otorhinolaryngologists and General Practitioners and Comparison with German Formulations.
    Kiselova O; Maurina B; Sidlovska V
    Int J Pharm Compd; 2020; 24(6):491-500. PubMed ID: 33217739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of Extemporaneous Prescriptions Prescribed by Dermatovenerologists in Latvia and Comparison with Standardized Compounded Preparation Monographs of Germany and USA.
    Kiseļova O; Mauriņa B; Šidlovska V
    Medicina (Kaunas); 2020 Jan; 56(1):. PubMed ID: 31936697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Drug policy in Slovakia and its reflection in prescriptions. 2. Prescriptions of individually prepared drugs based on the medical specialty].
    Springer V; Kisska I
    Ceska Slov Farm; 2002 Jul; 51(4):186-9. PubMed ID: 12183906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the most frequently prescribed extemporaneously compounded medications in a rural setting: a case study from the Delmarva Peninsula.
    Sherr Z; Karara AH
    Int J Pharm Compd; 2014; 18(6):462-8. PubMed ID: 25906622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety Aspects of Extemporaneous Prescriptions Prescribed by Latvian Healthcare Specialists.
    Kiselova O; Maurina B; Sidlovska V
    Int J Pharm Compd; 2021; 25(4):288-295. PubMed ID: 34297690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence, determinants, and characteristics of extemporaneous compounding in Jordanian pharmacies.
    AlKhatib HS; Jalouqa S; Maraqa N; Ratka A; Elayeh E; Al Muhaissen S
    BMC Health Serv Res; 2019 Nov; 19(1):816. PubMed ID: 31703672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the Most Frequently Prescribed Extemporaneously Compounded Veterinary Medications at a Large Independent Community Pharmacy.
    Karara AH; Hines R; Demir Z; Nnorom B; Horsey R; Twigg G
    Int J Pharm Compd; 2016; 20(6):461-467. PubMed ID: 28339384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Extent of Extemporaneous Preparation and Regulatory Framework of Extemporaneous Compounding in Latvia.
    Kiseļova O; Mauriņa B; Šidlovska V; Zvejnieks J
    Medicina (Kaunas); 2019 Aug; 55(9):. PubMed ID: 31454896
    [No Abstract]   [Full Text] [Related]  

  • 10. Dispensing of psychotropic drugs to adults in community pharmacies in Latvia.
    Vrublevska K; Rukmane J; Burmistrs R; Sipols J; Muceniece R
    Pharm World Sci; 2008 Dec; 30(6):934-9. PubMed ID: 18839330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence, Scope and Quality of Extemporaneous Medications in Selected Healthcare Facilities and Implications for Pharmacy Practice.
    Allotey-Babington GL; Akwo Kretchy I; Atiapa Asiedu E; Kelly Amuakwa M; Akwele Seaneke O; Ankrah D; Kwadwo Somuah A; Dei Owusu-Nyamekye A; Owusu-Ansah S; Kwame Effah P; Debrah J; Acheampomaa Nai E; Owusu E; Lamptey W; Gyekye IJA; Nettey H
    Innov Pharm; 2024; 15(1):. PubMed ID: 38779112
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmaceutical counseling: Between evidence-based medicine and profits.
    Egorova SN; Akhmetova T
    Int J Risk Saf Med; 2015; 27 Suppl 1():S87-8. PubMed ID: 26639727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stability considerations in liquid dosage forms extemporaneously prepared from commercially available products.
    Glass BD; Haywood A
    J Pharm Pharm Sci; 2006; 9(3):398-426. PubMed ID: 17207422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Investigation of Prescription Indicators and Trends Among General Practitioners and Specialists From 2005 to 2015 in Kerman, Iran.
    Masoud A; Noori Hekmat S; Dehnavieh R; Haj-Akbari N; Poursheikhali A; Abdi Z
    Int J Health Policy Manag; 2018 Sep; 7(9):818-827. PubMed ID: 30316230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prescription and structure of formulation of medicinal preparations in a pharmacy. II].
    Kolár J; Svejdová J
    Ceska Slov Farm; 2005 Jan; 54(1):29-33. PubMed ID: 15751792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
    Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
    MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extemporaneous compounding of oral liquid dosage formulations and alternative drug delivery methods for anticancer drugs.
    Lam MS
    Pharmacotherapy; 2011 Feb; 31(2):164-92. PubMed ID: 21275495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Availability of prescription drugs for bipolar disorder at online pharmacies.
    Monteith S; Glenn T; Bauer R; Conell J; Bauer M
    J Affect Disord; 2016 Mar; 193():59-65. PubMed ID: 26766033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The possibilities of innovation of extemporaneous preparation in pharmacies in the Czech Republic].
    Sklenář Z; Horáčková K
    Ceska Slov Farm; 2012 Feb; 61(1-2):11-6. PubMed ID: 22536647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extemporaneous formulations in Germany - relevance for everyday clinical practice.
    Staubach P; Salzmann S; Peveling-Oberhag A; Weyer V; Zimmer S; Gradl G; Lang BM
    J Dtsch Dermatol Ges; 2018 May; 16(5):566-574. PubMed ID: 29750454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.